Matthew Greenhawt
Corporate Officer/Principal en Intrommune Therapeutics, Inc. .
Cargos activos de Matthew Greenhawt
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
Intrommune Therapeutics, Inc.
 Intrommune Therapeutics, Inc. MiscellaneousMiscellaneous Intrommune Therapeutics, Inc. operates as a biopharmaceutical company. The firm develops oral mucosal immunotherapy(OMIT) platform for food allergies. The company was founded by Michael Nelson and William Reisacher in 2015 and is headquartered in New York, NY. | Corporate Officer/Principal | - | - |
Historial de carrera de Matthew Greenhawt
Estadísticas
Internacional
| Estados Unidos | 2 |
Operativa
| Corporate Officer/Principal | 1 |
Sectorial
| Miscellaneous | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas privadas | 1 |
|---|---|
Intrommune Therapeutics, Inc.
Intrommune Therapeutics, Inc. MiscellaneousMiscellaneous Intrommune Therapeutics, Inc. operates as a biopharmaceutical company. The firm develops oral mucosal immunotherapy(OMIT) platform for food allergies. The company was founded by Michael Nelson and William Reisacher in 2015 and is headquartered in New York, NY. | Miscellaneous |
- Bolsa de valores
- Insiders
- Matthew Greenhawt
- Experiencia
